ISCT Leads Global Scientific Consortia to Respond to Recent FDA Report on Risk of T-Cell Malignancy in Patients Following CAR T-Cell Immunotherapies : vimarsana.com
/PRNewswire/ - The International Society for Cell & Gene Therapy (ISCT), the global society of clinicians, researchers, regulators, technologists, and industry...